about
What's the place of immunotherapy in malignant mesothelioma treatments?Proteomic footprinting of drug-treated cancer cells as a measure of cellular vaccine efficacy for the prevention of cancer recurrenceTargeting IL-23 in human diseases.Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors.Antitumor immune activity by chemokine CX3CL1 in an orthotopic implantation of lung cancer model in vivo.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New frontiers in cell-based immunotherapy of cancer.
@en
New frontiers in cell-based immunotherapy of cancer.
@nl
type
label
New frontiers in cell-based immunotherapy of cancer.
@en
New frontiers in cell-based immunotherapy of cancer.
@nl
prefLabel
New frontiers in cell-based immunotherapy of cancer.
@en
New frontiers in cell-based immunotherapy of cancer.
@nl
P2860
P1476
New frontiers in cell-based immunotherapy of cancer
@en
P2093
Amedeo Amedei
Gianfranco Del Prete
P2860
P304
P356
10.1517/13543770902817820
P407
P577
2009-05-01T00:00:00Z